Hookipa Pharma Inc. is a clinical stage company developing products to prevent and cure infectious diseases and cancer. With this goal in mind we created unique and cutting-edge technologies which reprogram and stimulate the immune system. Our Arenavirus technologies, Vaxwave®, a replication-deficient viral vector, and TheraT®, an attenuated replicating vector, induce potent pathogen-neutralizing antibodies and CD8+ T cells. Both, can be administered repeatedly while maintaining their efficacy.
Helmut-Qualtinger-Gasse 2
1030 Vienna
Vienna
Contact:
Telephone: +43 (1) 8906360
Email: office@hookipabiotech.com
Website